• What's pneu part 3: pneumococcal vaccines update

  • Feb 25 2025
  • Durée: 22 min
  • Podcast

What's pneu part 3: pneumococcal vaccines update

  • Résumé

  • The widespread use of pneumococcal conjugate vaccine (PCV) in children has dramatically lowered the incidence of pneumococcal disease through direct and indirect effects. Despite this progress, pneumococcal pneumonia still leads to more than 200,000 adult hospitalizations annually in the United States. Older adults, individuals with underlying health conditions, and certain racial groups continue to experience higher rates of pneumococcal disease. Dr. John Schoen, Senior Clinical Manager of Drug Information at the Vizient Center for Pharmacy Practice Excellence, joins Program Host Stacy Lauderdale to discuss the newest adult pneumococcal vaccine, PCV21, and recent updates to age-based pneumococcal vaccine recommendations.

    Guest speakers:

    John Schoen, Pharm.D, BCPS

    Senior Clinical Manager of Drug Information

    Vizient Center for Pharmacy Practice Excellence

    Host:

    Stacy Lauderdale, Pharm.D, BCPS

    Associate Vice President

    Vizient Center for Pharmacy Practice Excellence

    VerifiedRx Host

    Show Notes:

    [01:25-02:53] Background on PCV21

    [02:54-07:56] Difference between PCV20 and PCV21

    [07:57-16:15] Discussing the new ACIP recommendation to move the universal age for pneumococcal vaccination from 65 years of age down to 50 years of age and older

    [08:31-16:15] Why a healthy 50-year-old who has no risk factors for invasive pneumococcal disease should get a pneumococcal vaccination

    [16:16-17:57] Summary of other changes in the most recent MMWR

    [17:58-19:34] What organizations consider when selecting specific pneumococcal vaccines

    [19:35-21:18] What’s in the pipeline for pneumococcal vaccines

    Links | Resources:

    Publicly available resources

    Previous VerifiedRx podcasts on pneumococcal vaccines:

    • What’s pneu with pneumococcal vaccines? – March 29, 2022
    • What’s pneu part 2: pneumococcal vaccines update – February 13, 2024

    January 2024 MMWR - ACIP recommendations for the use of PCV in adults ≥ 50 years of age

    Vizient client exclusive resources

    2025 pneumococcal vaccines side-by-side comparison

    Subscribe Today!

    Apple Podcasts

    Amazon Podcasts

    Spotify

    Android

    RSS Feed

    Voir plus Voir moins

Ce que les auditeurs disent de What's pneu part 3: pneumococcal vaccines update

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.